MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$26,602K
(34.60%↑ Y/Y)
Interest income
$807K
(-50.25%↓ Y/Y)
Loss before
provision for income taxes
$26,102K
Provision for income taxes
$500K
Total other income,
net
$450K
(-45.52%↓ Y/Y)
Interest expense
-$357K
(55.15%↑ Y/Y)
Loss from operations
-$26,552K
(36.02%↑ Y/Y)
Collaboration revenue
$27,466K
(195.75%↑ Y/Y)
Total operating
expenses
$54,018K
(6.36%↑ Y/Y)
Research and development
$37,743K
(3.99%↑ Y/Y)
General and
administrative
$16,244K
(11.37%↑ Y/Y)
Loss (gain) on fixed
asset disposal
-$31K
(-133.33%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Cue Biopharma, Inc. (CUE)
Cue Biopharma, Inc. (CUE)